Orion 

$7.94
140
-$0.19-2.34% Tuesday 20:00

Statistics

Day High
8.27
Day Low
7.55
52W High
11.62
52W Low
4.35
Volume
427,823
Avg. Volume
-
Mkt Cap
445.86M
P/E Ratio
-
Dividend Yield
1.04%
Dividend
0.08

Upcoming

Dividends

1.04%Dividend Yield
Jul 26
$0.02
Apr 26
$0.02
Jan 26
$0.02
Oct 25
$0.02
Jul 25
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.11
0.65
1.41
2.17
Expected EPS
0.152611
Actual EPS
N/A

Financials

-3.88%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.61BRevenue
-140.2MNet Income

Analyst Ratings

6.38Average Price Target
The highest estimate is 7.50.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
50%
Sell
50%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OEC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap194.35B
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This competes directly with Orion's pharmaceutical products, especially in the diabetes and hormone replacement sectors.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is a global pharmaceutical corporation which competes across various therapeutic areas including oncology, neurology, and immunology, overlapping with Orion's product portfolio.
Merck
MRK
Mkt Cap294.03B
Merck & Co., Inc. is known for its contributions to pharmaceuticals across a range of conditions, directly competing with Orion in areas like cancer and neurodegenerative diseases.
Astrazeneca
AZN
Mkt Cap277.22B
AstraZeneca operates in key areas such as oncology, cardiovascular, renal & metabolism, and respiratory & immunology, which are also focus areas for Orion, making them direct competitors.
GSK
GSK
Mkt Cap106.31B
GlaxoSmithKline is a global healthcare company that researches and develops a broad range of innovative products in pharmaceuticals, vaccines, and consumer healthcare, competing with Orion especially in the respiratory and CNS sectors.
Rogers
ROG
Mkt Cap2.7B
Roche Holding AG is a pioneer in healthcare, leading in cancer treatments and diagnostics, directly competing with Orion's oncology and diagnostic products.
Novartis
NVS
Mkt Cap292.07B
Novartis is one of the largest pharmaceutical companies by both market cap and sales, competing in areas like oncology, neurology, and immunology, similar to Orion.
Sanofi
SNY
Mkt Cap105.92B
Sanofi focuses on pharmaceuticals and human vaccines, with a strong presence in diabetes, oncology, and rare diseases, areas that Orion also operates in.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty medicines, competing with Orion in the provision of generic drugs and active pharmaceutical ingredients.

About

Orion Engineered Carbons S.A., operating globally through its subsidiaries, specializes in the production and distribution of carbon black products across a wide international footprint, including major markets like Germany, the United States, South Korea, Brazil, China, South Africa, and other European countries. The company organizes its business into two primary divisions: Specialty Carbon Black and Rubber Carbon Black. Within its Specialty Carbon Black segment, Orion provides a diverse range of offerings such as specially treated grades designed for coatings and printing applications, high-purity options for the fiber industry, and conductive variants essential for polymers, various coating types, and battery electrodes. Furthermore, its Rubber Carbon Black division supplies products specifically formulated for mechanical rubber applications, marketed under the PUREX brand, and for tire manufacturing, known by the ECORAX brand. The company, which was initially incorporated as Orion Engineered Carbons S.à r.l., adopted its current name, Orion Engineered Carbons S.A., in July 2014. Established in 1862, Orion Engineered Carbons S.A. maintains its corporate headquarters in Senningerberg, Luxembourg.
Show more...
CEO
Mr. Corning F. Painter
Employees
1658
Country
United States
ISIN
LU1092234845

Listings

0 Comments

Share your thoughts

FAQ

What is Orion stock price today?
The current price of OEC is $7.94 USD — it has decreased by -2.34% in the past 24 hours. Watch Orion stock price performance more closely on the chart.
What is Orion stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Orion stocks are traded under the ticker OEC.
Is Orion stock price growing?
OEC stock has risen by +10.28% compared to the previous week, the month change is a +14.74% rise, over the last year Orion has showed a -21.93% decrease.
What is Orion market cap?
Today Orion has the market capitalization of 445.86M
When is the next Orion earnings date?
Orion is going to release the next earnings report on July 30, 2026.
What were Orion earnings last quarter?
OEC earnings for the last quarter are -0.11 USD per share, whereas the estimation was 0.07 USD resulting in a -267.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Orion revenue for the last year?
Orion revenue for the last year amounts to 3.61B USD.
What is Orion net income for the last year?
OEC net income for the last year is -140.2M USD.
Does Orion pay dividends?
Yes, OEC dividends are paid quarterly. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 1.04%.
How many employees does Orion have?
As of June 17, 2026, the company has 1,658 employees.
In which sector is Orion located?
Orion operates in the Materials sector.
When did Orion complete a stock split?
Orion has not had any recent stock splits.
Where is Orion headquartered?
Orion is headquartered in Senningerberg, United States.